Feline Transdermal Formulation Considerations
Download in electronic PDF format for $75
Abstract: Transdermal delivery of drugs is comparatively new in feline patients. However, transdermal formulations can be a desirable option for treating feline patients that are not willing participants to medication administration. However, achieving drug penetration across the skin is not always easy, and there are a wide variety of variables that can further affect penetration. This, coupled with a lack of studies, make transdermal administration an unknown with regards to efficacy and safety for many drugs. This article focuses on drugs that are administered transdermally with the intent of producing systemic effects.
Related Keywords:
cats, veterinary compounding, transdermal delivery, drug penetration, drug safety, topical preparations, drug absorption, skin structure, dermal penetration enhancer, stratum corneum thickness
Related Categories:
EXCIPIENTS, STABILITIES, COMPATIBILITIES, VETERINARY, DOSAGE FORMS/DRUG CARRIERS
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
|
Nov/Dec 2017
Pg. 446-452
|
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John, Light Bob
|
May/Jun 2016
Pg. 250-256
|
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O, Light Bob
|
Nov/Dec 2017
Pg. 530-535
|
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
|
Nov/Dec 2018
Pg. 498-503
|
Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 308-315
|
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013
Pg. 247-253
|
Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 400-408
|
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R, Davidson Gigi S
|
Sep/Oct 2014
Pg. 366-369
|
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie, Asbill Scott, Eagerton David, Arnold John
|
Nov/Dec 2014
Pg. 512-515
|
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Arnold John J, Asbill Scott
|
Nov/Dec 2009
Pg. 569-571
|
Skin Penetration and Antinociception of Topical Gabapentin Formulations
Bryson Evan, Asbill Scott, Sweitzer Sarah
|
Nov/Dec 2014
Pg. 504-511
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
Chemical Penetration Enhancers
Newton Stephen J
|
Sep/Oct 2013
Pg. 370-374
|
Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
|
Jul/Aug 2016
Pg. 271-274
|
NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 446-448
|
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Teimouri Arezou, Yeung Pollen, Agu Remigius U
|
Nov/Dec 2020
Pg. 501-508
|
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Goodwin Donald A, Fuhram L Clifton
|
Nov/Dec 1999
Pg. 496-500
|
Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 385-395
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
| Return to Top |
